The medical team who performed the 50th HyCASA surgery at the Hollywood private hospital
Hollywood Private Hospital celebrates milestone as the Southern Hemisphere’s sole provider of innovative treatment for fatal heart disease.
In August 2021, the Perth facility completed its 50e Procedure using the HyCASA method – Hybrid Catheter Ablation and Surgical Ablation – to remedy persistent atrial fibrillation (AF).
AF, an abnormal heart rhythm caused by erratic electrical signals in the heart, affects around two percent of the Australian population.
The disease increases the risk of chronic fatigue, decreased activity levels and decreased quality of life.
In 2017-18, it accounted for more than 72,000 hospitalizations nationwide and was associated with 9% of deaths in 2018.
“AF is a progressive disease, so it is important that patients are diagnosed and treated before it progresses and causes other health problems, such as stroke or heart failure,” said Hollywood Private Hospital Director of Medical Services, Dr Andy Papa-Adams.
“The HyCASA treatment has a proven track record, with over 9,000 procedures performed in the United States and Europe, and we are extremely proud to offer it. “
HyCASA aims to interrupt atrial fibrillation circuits and return the heart to a normal rhythm. It treats both the inside and the outside of the heart with radiofrequency endocardial ablation and epicardial ablation.
“It is estimated that almost half of patients with AF have long-standing and persistent AF,” said Dr Papa-Adams.
“HyCASA targets two key areas where AF originates: the pulmonary veins and the back wall of the heart.”
Symptoms of AF include palpitations, a throbbing sensation in the chest, a fast or irregular heartbeat, shortness of breath and dizziness – Dr Papa-Adams said anyone with one or more of these symptoms should see their doctor. general practitioner.
The medical team was able to perform the procedure thanks to the hospital’s new multi-million dollar cardiothoracic theater, launched in late 2020.
“Hollywood will be an important center for hybrid therapy for AF and a potential surveillance site for the southern hemisphere,” said Dr. Papa-Adams.
“We are on the cusp of becoming a training center for the procedure, teaching surgeons and electrophysiologists across Australia, New Zealand and the Asia-Pacific region.”
Hollywood Private CEO Peter Mott said the hospital’s mission is to bring innovative therapies to patients who previously had limited options.
“Our new cardiothoracic theater is part of a $ 200 million investment by Ramsay Health Care to provide comprehensive health services at a convenient location in Nedlands,” said Mott.
“Hollywood will be a comprehensive heart health facility with the opening of our emergency department later this year.”